A Multi-Center Clinical Trial of Allopurinol to Prevent Renal Function (GFR) Loss in Type 1 Diabetes


​The purpose of this study is to find out whether a medication called allopurinol can prevent kidney problems, in particular, the loss of kidney function, in people with type 1 diabetes.

Recruitment: This study is not currently recruiting.

​This study is no longer recruiting.


​Principal Investigator: Dr. Allesandro Doria